ERISPharmaceuticals
Eris Lifesciences Ltd — Balance Sheet
₹1297.20
+2.05%
Eris Lifesciences Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 13.62 Cr | 13.60 Cr | 13.60 Cr | 13.59 Cr | — |
| Share Issued | 13.62 Cr | 13.60 Cr | 13.60 Cr | 13.59 Cr | — |
| Net Debt | 2.22K Cr | 2.64K Cr | 774.07 Cr | — | — |
| Total Debt | 2.48K Cr | 2.78K Cr | 876.71 Cr | 84.41 Cr | — |
| Tangible Book Value | -1.79K Cr | -1.19K Cr | -16.46 Cr | 1.16K Cr | — |
| Invested Capital | 5.28K Cr | 5.32K Cr | 3.03K Cr | 1.95K Cr | — |
| Working Capital | -158.40 Cr | -230.03 Cr | 321.49 Cr | 427.68 Cr | — |
| Net Tangible Assets | -1.79K Cr | -1.19K Cr | -16.46 Cr | 1.16K Cr | — |
| Capital Lease Obligations | 56.26 Cr | 46.00 Cr | 46.70 Cr | 39.40 Cr | — |
| Common Stock Equity | 2.85K Cr | 2.59K Cr | 2.20K Cr | 1.91K Cr | — |
| Total Capitalization | 4.59K Cr | 3.24K Cr | 2.84K Cr | 1.95K Cr | — |
| Total Equity Gross Minority Interest | 3.27K Cr | 3.22K Cr | 2.22K Cr | 1.91K Cr | — |
| Minority Interest | 417.40 Cr | 635.91 Cr | 24.69 Cr | -0.11 Cr | — |
| Stockholders Equity | 2.85K Cr | 2.59K Cr | 2.20K Cr | 1.91K Cr | — |
| Other Equity Interest | 10.09 Cr | 5.02 Cr | 2.80 Cr | 1.90 Cr | — |
| Retained Earnings | 2.79K Cr | 2.54K Cr | 2.16K Cr | 1.87K Cr | — |
| Additional Paid In Capital | 29.51 Cr | 18.24 Cr | 15.28 Cr | 10.79 Cr | — |
| Capital Stock | 13.62 Cr | 13.60 Cr | 13.60 Cr | 13.59 Cr | — |
| Common Stock | 13.62 Cr | 13.60 Cr | 13.60 Cr | 13.59 Cr | — |
| Total Liabilities Net Minority Interest | 3.76K Cr | 3.82K Cr | 1.45K Cr | 363.94 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 2.38K Cr | 1.29K Cr | 1.00K Cr | 164.29 Cr | — |
| Other Non Current Liabilities | 4.58 Cr | 1.38 Cr | 11.32 Cr | 2.28 Cr | — |
| Non Current Deferred Revenue | 4.47 Cr | 1.38 Cr | 1.82 Cr | 5.69 Cr | — |
| Non Current Deferred Taxes Liabilities | 518.45 Cr | 534.39 Cr | 257.64 Cr | 46.09 Cr | — |
| Long Term Debt And Capital Lease Obligation | 1.78K Cr | 691.53 Cr | 683.42 Cr | 80.39 Cr | — |
| Long Term Capital Lease Obligation | 44.21 Cr | 37.02 Cr | 38.97 Cr | 35.39 Cr | — |
| Long Term Debt | 1.74K Cr | 654.51 Cr | 644.45 Cr | 45.00 Cr | — |
| Long Term Provisions | 68.98 Cr | 52.72 Cr | 44.12 Cr | 32.11 Cr | — |
| Current Liabilities | 1.38K Cr | 2.53K Cr | 443.23 Cr | 199.65 Cr | — |
| Other Current Liabilities | 42.68 Cr | 27.59 Cr | 17.92 Cr | 15.24 Cr | — |
| Current Debt And Capital Lease Obligation | 696.20 Cr | 2.09K Cr | 193.29 Cr | 4.01 Cr | — |
| Current Capital Lease Obligation | 12.05 Cr | 8.98 Cr | 7.72 Cr | 4.00 Cr | — |
| Current Debt | 684.15 Cr | 2.08K Cr | 185.57 Cr | 0.01 Cr | — |
| Current Provisions | 78.09 Cr | 62.05 Cr | 69.44 Cr | 39.06 Cr | — |
| Payables | 542.85 Cr | 327.31 Cr | 143.67 Cr | 127.64 Cr | — |
| Other Payable | 166.79 Cr | 68.69 Cr | 14.90 Cr | 2.80 Cr | — |
| Dividends Payable | 0.10 Cr | 0.10 Cr | 0.10 Cr | 0.08 Cr | — |
| Total Tax Payable | 43.61 Cr | 39.59 Cr | 3.90 Cr | 7.00 Cr | — |
| Accounts Payable | 332.35 Cr | 218.93 Cr | 124.77 Cr | 117.77 Cr | — |
| Total Assets | 7.03K Cr | 7.04K Cr | 3.67K Cr | 2.27K Cr | — |
| Total Non Current Assets | 5.81K Cr | 4.74K Cr | 2.90K Cr | 1.64K Cr | — |
| Other Non Current Assets | 0.18 Cr | 0.17 Cr | 10000.00 | 24.34 Cr | — |
| Non Current Prepaid Assets | 12.59 Cr | 11.41 Cr | 9.66 Cr | 4.50 Cr | — |
| Non Current Deferred Taxes Assets | 289.04 Cr | 306.95 Cr | 273.94 Cr | 243.13 Cr | — |
| Investmentin Financial Assets | 10.71 Cr | 15.73 Cr | 6.88 Cr | 420.84 Cr | — |
| Available For Sale Securities | 0.70 Cr | 0.68 Cr | 6.55 Cr | 2.86 Cr | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 10.01 Cr | 15.05 Cr | 0.33 Cr | 417.10 Cr | — |
| Long Term Equity Investment | 51.49 Cr | 0.00 | — | — | — |
| Investmentsin Joint Venturesat Cost | 51.49 Cr | 0.00 | — | — | — |
| Goodwill And Other Intangible Assets | 4.64K Cr | 3.78K Cr | 2.21K Cr | 753.07 Cr | — |
| Other Intangible Assets | 3.73K Cr | 2.91K Cr | 1.88K Cr | 659.60 Cr | — |
| Goodwill | 911.97 Cr | 867.17 Cr | 331.85 Cr | 93.47 Cr | — |
| Net PPE | 755.87 Cr | 568.82 Cr | 389.17 Cr | 216.20 Cr | — |
| Accumulated Depreciation | -221.31 Cr | -145.04 Cr | -93.37 Cr | -74.98 Cr | — |
| Gross PPE | 977.18 Cr | 713.86 Cr | 482.54 Cr | 291.19 Cr | — |
| Construction In Progress | 93.81 Cr | 29.57 Cr | 33.17 Cr | 48.35 Cr | — |
| Other Properties | 236.14 Cr | 208.15 Cr | 153.95 Cr | 110.06 Cr | — |
| Machinery Furniture Equipment | 271.72 Cr | 218.76 Cr | 139.25 Cr | 72.16 Cr | — |
| Buildings And Improvements | 257.98 Cr | 208.30 Cr | 133.26 Cr | 41.08 Cr | — |
| Land And Improvements | 117.53 Cr | 49.08 Cr | 22.92 Cr | 19.53 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 1.22K Cr | 2.30K Cr | 764.72 Cr | 627.33 Cr | — |
| Other Current Assets | 4.05 Cr | 3.65 Cr | 247.35 Cr | 106.08 Cr | — |
| Restricted Cash | 22.46 Cr | 61.89 Cr | 2.51 Cr | 1.46 Cr | — |
| Prepaid Assets | 89.88 Cr | 143.42 Cr | 86.43 Cr | 87.20 Cr | — |
| Inventory | 334.83 Cr | 189.03 Cr | 131.44 Cr | 117.91 Cr | — |
| Finished Goods | 194.08 Cr | 105.81 Cr | 81.93 Cr | 76.11 Cr | — |
| Work In Process | 7.93 Cr | 10.58 Cr | 3.84 Cr | 1.98 Cr | — |
| Raw Materials | 132.82 Cr | 72.64 Cr | 45.66 Cr | 39.82 Cr | — |
| Other Receivables | 5.82 Cr | 6.32 Cr | 9.12 Cr | 25.60 Cr | — |
| Taxes Receivable | 101.94 Cr | 136.96 Cr | 156.56 Cr | 21.87 Cr | — |
| Accounts Receivable | 458.64 Cr | 422.03 Cr | 292.71 Cr | 160.97 Cr | — |
| Allowance For Doubtful Accounts Receivable | -34.89 Cr | -22.39 Cr | -3.52 Cr | -3.52 Cr | — |
| Gross Accounts Receivable | 493.53 Cr | 444.42 Cr | 296.23 Cr | 164.49 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 205.37 Cr | 1.34K Cr | 85.95 Cr | 212.32 Cr | — |
| Other Short Term Investments | 5.73 Cr | 1.24K Cr | 30.01 Cr | 161.45 Cr | — |
| Cash And Cash Equivalents | 199.64 Cr | 94.14 Cr | 55.95 Cr | 50.87 Cr | — |
| Cash Financial | 199.64 Cr | 94.14 Cr | 55.95 Cr | 50.87 Cr | — |
| Treasury Shares Number | — | 0.00 | — | 0.00 | — |
| Other Inventories | — | 10000.00 | — | — | — |
| Tradeand Other Payables Non Current | — | — | 9.50 Cr | — | — |
| Held To Maturity Securities | — | — | 0.83 Cr | 0.88 Cr | 0.86 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Eris Lifesciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.